Literature DB >> 19837217

Improved survival after coronary artery bypass grafting has not influenced the mortality disadvantage in patients with diabetes mellitus.

Thomas Alserius1, Niklas Hammar, Tobias Nordqvist, Torbjörn Ivert.   

Abstract

OBJECTIVES: We sought to compare mortality after coronary artery bypass grafting in patients with and without diabetes mellitus undergoing operations during different time periods.
METHODS: We performed analyses of 12,415 primary isolated coronary artery bypass grafting operations performed during 1970-2003, with follow-up of 5-year mortality up to December 2006.
RESULTS: The prevalence of diabetes mellitus continuously increased up to 25% among patients undergoing coronary artery bypass grafting in 2003. The 1892 patients with type 2 diabetes mellitus were older, more often female, and more frequently had cardiovascular risk factors, acute coronary syndrome, 3-vessel disease, and severely reduced left ventricular function than patients without diabetes mellitus. Early mortality was 3.4% in patients with diabetes mellitus versus 1.8% in patients without diabetes mellitus. The multivariable adjusted odds ratio was 2.0, and the 95% confidence interval was 1.4 to 2.7. Early adjusted mortality was significantly lower in patients operated on during 2000-2003 than those operated on during 1970-1989 in patients with diabetes mellitus (odds ratio, 0.3; 95% confidence interval, 0.1-0.9) and without diabetes mellitus (odds ratio, 0.4; 95% confidence interval, 0.2-0.7). Mortality until 5 years was 14.6% in patients with diabetes mellitus versus 8.3% in patients without diabetes mellitus (hazard ratio, 1.8; 95% confidence interval, 1.5-2.0). Five-year mortality was reduced by 40% in patients operated on during 2000-2003 compared with that seen in those operated on during 1970-1989 in patients with and without diabetes mellitus.
CONCLUSIONS: Diabetes mellitus was associated with an almost 2-fold increased risk of early and 5-year mortality. Early and late mortality were substantially reduced in patients with and without diabetes mellitus operated on more recently, but the mortality disadvantage associated with diabetes mellitus was not eliminated.

Entities:  

Mesh:

Year:  2009        PMID: 19837217     DOI: 10.1016/j.jtcvs.2009.03.013

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

1.  The current status of multi-arterial off-pump coronary artery bypass grafting.

Authors:  Suzuki Tomoaki; Asai Tohru
Journal:  Surg Today       Date:  2015-02-13       Impact factor: 2.549

2.  Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.

Authors:  Ruben E Hernandez; Steve K Singh; Dale T Hoang; Syed W Ali; MacArthur A Elayda; Hari R Mallidi; O H Frazier; Deborah E Meyers
Journal:  Tex Heart Inst J       Date:  2015-10-01

3.  Effect of type 2 diabetes, surgical incision, and volatile anesthesia on hemodynamics in the rat.

Authors:  Carol T Bussey; Regis R Lamberts
Journal:  Physiol Rep       Date:  2017-07

4.  Glycated Hemoglobin as a Predictor of the Length of Hospital Stay in Patients Following Coronary Bypass Graft Surgery in the Saudi Population.

Authors:  Joud G Almogati; Elnazeer O Ahmed
Journal:  Braz J Cardiovasc Surg       Date:  2019 Jan-Feb

5.  Improving long term outcome for diabetic patients undergoing surgical revascularization by use of the radial artery conduit: a propensity matched study.

Authors:  Darryl M Hoffman; Kamellia R Dimitrova; Helbert Decastro; Patricia Friedmann; Charles M Geller; Wilson Ko; Robert F Tranbaugh
Journal:  J Cardiothorac Surg       Date:  2013-02-19       Impact factor: 1.637

6.  Increased haemodynamic adrenergic load with isoflurane anaesthesia in type 2 diabetic and obese rats in vivo.

Authors:  Carol T Bussey; Anne E de Leeuw; Regis R Lamberts
Journal:  Cardiovasc Diabetol       Date:  2014-12-10       Impact factor: 9.951

7.  Comparison of endothelial function of coronary artery bypass grafts in diabetic and nondiabetic patients: Which graft offers the best?

Authors:  Demet Özkaramanlı Gür; Özcan Gür; Selami Gürkan; Selcem Cömez; Aylin Gönültaş; Murat Yılmaz
Journal:  Anatol J Cardiol       Date:  2015-08       Impact factor: 1.596

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.